Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

BCS

Notice of Proposed Sale · 144

Bausch + Lomb Corporation

Notice of Proposed Sale

Filed Sep 28, 2026Accepted Sep 28, 2026, 3:10 PM EDTFiling CIK 1860742Accession 0001959173-26-007126
Share

Structured filing — 144

primary_doc.xml

Open full document ↗

Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.

Proposed-sale notice

Issuer
Bausch & Lomb Corp
Issuer CIK
0001860742
SEC file number
001-41380
Phone
908-541-5456
Person for whose account securities are to be sold
Ling Karen
Relationships to issuer
Former Director
Street
520 APPLEWOOD CRESCENT
City
VAUGHAN
State / country code
A6
Postal code
L4K 4B4

Securities proposed for sale

Securities proposed for sale · 1 reported row
SecurityProposed unitsAggregate market valueUnits outstandingApproximate sale dateExchangeBroker / market maker
Common4,50075,735.00357,165,24609/28/2026NYSEFidelity Brokerage Services LLC

Broker / market maker — proposed row 1, entry 1

Name
Fidelity Brokerage Services LLC
Street
900 Salem Street
City
Smithfield
State / country code
RI
Postal code
02917

Acquisition of securities to be sold

Acquisition of securities to be sold · 2 reported rows
SecurityAcquiredNature of acquisitionAcquired fromAmount acquiredGift transactionPayment dateNature of payment
Common05/28/2024Restricted Stock VestingIssuer2,642N05/28/2024Compensation
Common05/20/2025Restricted Stock VestingIssuer1,858N05/20/2025Compensation

Prior-sale reporting

Nothing to report for the preceding three months
Y

Notice signature

Notice date
09/28/2026
Signed
/s/ Gary Redman, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Karen Ling

Company context

Our mission is simple - we help people see better to live better, all over the world. For nearly two centuries we’ve evolved with the changing needs of patients and customers, and our commitment to innovation and improving the standard of care in eye health has never been stronger. From contact lenses to prescription products, over-the-counter options, surgical devices and more, we’re turning bold ideas into better outcomes through passion, perseverance and purpose. Learn more at www.bausch.com and connect with us on Facebook, Instagram, LinkedIn, X and YouTube.

Current securities

Recent company filings

  1. 4 filingAug 14, 2026
  2. 3 filingAug 14, 2026
  3. 4 filingAug 14, 2026
  4. 3 filingAug 14, 2026
  5. 4 filingAug 14, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.